Suppr超能文献

基于胱抑素 C、肌酐及其组合的肾小球滤过率方程在危重症患者中的预测性能。

Predictive performance of glomerular filtration rate equations based on cystatin C, creatinine and their combination in critically ill patients.

机构信息

Pharmacy Service, Division of Medicines, Hospital Clinic de Barcelona, Barcelona, Catalunya, Spain.

Pharmacy Service, Division of Medicines, Hospital Clinic de Barcelona, Barcelona, Catalunya, Spain

出版信息

Eur J Hosp Pharm. 2024 Oct 25;31(6):543-549. doi: 10.1136/ejhpharm-2023-003738.

Abstract

OBJECTIVE

24-hour urine creatinine clearance (ClCr 24 hours) remains the gold standard for estimating glomerular filtration rate (GFR) in critically ill patients; however, simpler methods are commonly used in clinical practice. Serum creatinine (SCr) is the most frequently used biomarker to estimate GFR; and cystatin C, another biomarker, has been shown to reflect GFR changes earlier than SCr. We assess the performance of equations based on SCr, cystatin C and their combination (SCr-Cyst C) for estimating GFR in critically ill patients.

METHODS

Observational unicentric study in a tertiary care hospital. Patients with cystatin C, SCr and ClCr 24 hours measurements in ±2 days admitted to an intensive care unit were included. ClCr 24 hours was considered the reference method. GFR was estimated using SCr-based equations: Chronic Kidney Disease Epidemiology Collaboration based on creatinine (CKD-EPI-Cr) and Cockcroft-Gault (CG); cystatin C-based equations: CKD-EPI-CystC and CAPA; and Cr-CystC-based equations: CKD-EPI-Cr-CystC. Performance of each equation was assessed by calculating bias and precision, and Bland-Altman plots were built. Further analysis was performed with stratified data into CrCl 24 hours <60, 60-130 and ≥130 mL/min/1.73 m.

RESULTS

We included 275 measurements, corresponding to 186 patients. In the overall population, the CKD-EPI-Cr equation showed the lowest bias (2.6) and best precision (33.1). In patients with CrCl 24 hours <60 mL/min/1.73 m, cystatin-C-based equations showed the lowest bias (<3.0) and CKD-EPI-Cr-CystC was the most accurate (13.6). In the subgroup of 60≤ CrCl 24 hours <130mL/min/1.73 m, CKD-EPI-Cr-CystC was the most precise (20.9). However, in patients with CrCl 24 hours ≥130mL/min/1.73 m, cystatin C-based equations underestimated GFR, while CG overestimated it (22.7).

CONCLUSIONS

Our study showed no evidence of superiority of any equation over the others for all evaluated parameters: bias, precision and Lin's concordance correlation coefficient. Cystatin C-based equations were less biased in individuals with impaired renal function (GFR <60 mL/min/1.73 m). CKD-EPI-Cr-CystC performed properly in patients with GFR from 60-130 mL/min/1.73 m and none of them were accurate enough in patients ≥130 mL/min/1.73 m.

摘要

目的

24 小时尿肌酐清除率(ClCr24 小时)仍然是评估危重症患者肾小球滤过率(GFR)的金标准;然而,在临床实践中通常使用更简单的方法。血清肌酐(SCr)是最常用的估计 GFR 的生物标志物;另一种生物标志物胱抑素 C 已被证明比 SCr 更早反映 GFR 变化。我们评估了基于 SCr、胱抑素 C 及其组合(SCr-Cyst C)的方程在评估危重症患者 GFR 中的表现。

方法

这是一项在三级护理医院进行的观察性单中心研究。纳入了在重症监护病房(ICU)住院并在±2 天内接受了胱抑素 C、SCr 和 ClCr24 小时测量的患者。ClCr24 小时被认为是参考方法。使用基于 SCr 的方程估计 GFR:基于肌酐的慢性肾脏病流行病学合作研究(CKD-EPI-Cr)和 Cockcroft-Gault(CG);基于胱抑素 C 的方程:CKD-EPI-CystC 和 CAPA;以及基于 Cr-CystC 的方程:CKD-EPI-Cr-CystC。通过计算偏倚和精度评估每个方程的性能,并绘制 Bland-Altman 图。进一步对 CrCl24 小时<60、60-130 和≥130 mL/min/1.73 m 的分层数据进行了分析。

结果

我们纳入了 275 次测量,对应 186 名患者。在总体人群中,CKD-EPI-Cr 方程的偏倚最低(2.6),精度最好(33.1)。在 CrCl24 小时<60 mL/min/1.73 m 的患者中,胱抑素 C 基于方程的方程显示出最低的偏倚(<3.0),并且 CKD-EPI-Cr-CystC 是最准确的(13.6)。在 60≤CrCl24 小时<130mL/min/1.73 m 的亚组中,CKD-EPI-Cr-CystC 是最精确的(20.9)。然而,在 CrCl24 小时≥130mL/min/1.73 m 的患者中,胱抑素 C 基于方程低估了 GFR,而 CG 高估了 GFR(22.7)。

结论

我们的研究没有证据表明任何方程在所有评估参数(偏倚、精度和 Lin 的一致性相关系数)上都优于其他方程。在肾功能受损(GFR<60 mL/min/1.73 m)的个体中,胱抑素 C 基于方程的偏倚较小。在 GFR 为 60-130 mL/min/1.73 m 的患者中,CKD-EPI-Cr-CystC 表现良好,而在 GFR≥130 mL/min/1.73 m 的患者中,没有一种方法足够准确。

相似文献

本文引用的文献

9
Chapter 1: Definition and classification of CKD.第1章:慢性肾脏病的定义和分类。
Kidney Int Suppl (2011). 2013 Jan;3(1):19-62. doi: 10.1038/kisup.2012.64.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验